Advertisement
-
1
Fowkes FG, Rudan D, Rudan I, et al: Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 282: 1329, 2013.
-
2
Gardner AW, Afaq A: Management of lower extremity peripheral arterial disease. J Cadiopulm Rehabil Prev 28: 349, 2008.
-
3
Bergiers S, Vaes B, Degryse J: To screen or not to screen for peripheral arterial disease in subjects aged 80 and over in primary health care: a cross-sectional analysis from the BELFRAIL study. BMC Fam Pract 12: 1, 2011.
-
4
Hirsch AT, Haskal ZJ, Hertzer NR, et al: ACC/AHA 2005 Practice Guidelines for the Management of Patients with Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic). Circulation 113: e463, 2006.
-
5
Bhasin N, Scott DJ: Ankle brachial pressure index: identifying cardiovascular risk and improving diagnostic accuracy. J R Soc Med 100: 4, 2007.
-
6
Terashi H, Kitano I, Tsuji Y: Total management of diabetic foot ulcerations: Kobe classification as a new classification of diabetic foot wounds. Keio J Med 60: 17, 2010.
-
7
Ogren M, Hedbland B, Engstrom G, et al: Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68-year-old men with diabetes: results from the population study “Men born in 1914” from Malmo, Sweden. Eur J Vasc Endovasc Surg 29: 182, 2005.
-
8
Mays RJ, Regensteiner JG: Therapy for peripheral artery disease: gaps in treating patients with claudication. Circulation 130: 929, 2014.
-
9
Arce-Esquivel AA, Bunker AK, Laughlin A: “Effects of Type 2 Diabetes on Arterial Endothelium, in Recent Advances in the Pathogenesis, Prevention and Management of Type 2 Diabetes and Its Complications, 1st Ed, edited by MB Zimering, p 155, Intech, Rijeka, Croatia, 2011.
-
10
Faglia E, Caravaggi C, Marchetti R, et al: Screening for peripheral artery disease by means of the ankle brachial index in newly diagnosed type 2 diabetic patients. Diabetes Med 22: 1310, 2005.
-
11
McDermott MM, Liu K, Greenland P, et al: Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 292: 453, 2004.
-
12
McDermott MM, Guralnik JM, Ferrucci L, et al: Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation 117: 2484, 2008.
-
13
McDermott MM, Guralnik JM, Tian L, et al: Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). J Am Coll Cardiol 53: 1056, 2009.
-
14
Gardner AW, Montgomery PS, Afaq A, et al: Patterns of ambulatory activity in subjects with and without intermittent claudication. J Vasc Surg 46: 1208, 2007.
-
15
Regensteiner JG, Hiatt WR, Coll JR, et al: The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med 13: 15, 2008.
-
16
Smolderen KG, Hoeks SE, Pedersen SS, et al: Lower-leg symptoms in peripheral arterial disease are associated with anxiety, depression, and anhedonia. Vasc Med 14: 297, 2009.
-
17
De Liefde II, Hoeks SE, Van Gestel YR, et al: The prognostic value of impaired walking distance on long-term outcome in patients with known or suspected peripheral arterial disease. Eur J Vasc Endovasc Surg 38: 482, 2009.
-
18
Anderson JL, Halperin JL, Albert NM, et al: Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127: 1425, 2013.
-
19
Conte MS, Pomposelli FB, Clair DG, et al: Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg 61: 2S, 2015.
-
20
Oka RK, Altman M, Giacomini JC, et al: Exercise patterns and cardiovascular fitness of patients with peripheral arterial disease. J Vasc Nurs 22: 109, 2004.
-
21
Cheetham DR, Burgess M, Ellis M, et al: Does supervised exercise offer adjuvant benefit over exercise advice alone for the treatment of intermittent claudication? a randomized trial. Eur J Vasc Endovasc Surg 27: 17, 2004.
-
22
Perkins JM, Collin J, Creasy TS, et al: Reprinted article “Exercise training versus angioplasty for stable claudication: long and medium term results of a prospective, randomised trial.” Eur J Vasc Endovasc Surg 42: S41, 2011.
-
23
Aboyans V, Desormais H, Lacroix P, et al: The general prognosis of patients with peripheral arterial disease differs according to the disease localization. J Am Coll Cardiol 55: 898, 2010.
-
24
Neuschwander TB, Macias BR, Hargens AR, et al: Mild external compression of the leg increases skin and muscle microvascular flow and muscle oxygenation during simulated venous hypertension. ISRN Vasc Med 2012: 1, 2012.
-
25
Banerjee P: Can electrical muscle stimulation of the legs produce cardiovascular exercise? J Clin Exp Cardiol 2: 1, 2011.
-
26
Abraham P, Mateus V, Bieuzen F, et al: Calf muscle stimulation with the Veinoplus device results in a significant increase in lower limb inflow without generating limb ischemia or pain in patients with peripheral artery disease. J Vasc Surg 57: 714, 2013.
-
27
Anderson SI, Whatling P, Hudlicka O, et al: Chronic transcutaneous electrical stimulation of calf muscles improves functional capacity without inducing systemic inflammation in claudicants. Eur J Vasc Endovasc Surg 27: 201, 2004.
-
28
Presern-Strukelj M, Poredos P: The influence of electrostimulation on the circulation of the remaining leg in patients with one-sided amputation. Angiology 53: 329, 2002.
-
29
Formosa C, Cassar K, Gatt A, et al: Hidden dangers revealed by misdiagnosed peripheral arterial disease using ABPI measurement. Diabetes Res Clin Pract 102: 112, 2013.
-
30
Jongert MW, Hendriks HJM, Van HJ, et al: KNGF-richtlijn claudication intermittens. Nederl Tijdschr Geneesk 113: 3, 2003.
-
31
Kruidenier LM, Nicolai SP, Willigendael EM, et al: Functional claudication distance: a reliable and valid measurement to assess functional limitation in patients with intermittent claudication. BMC Cardiovasc Disord 9: 1, 2009.
-
32
Gardner AW, Skinner JS, Canwell BW, et al: Progressive vs single-stage treadmill test for evaluation of claudication. Med Sci Sports Exerc 23: 402, 1991.
-
33
Duprez D, de Backer T, de Buyzere M, et al: Estimation of walking distance and intermittent claudication: need for standardization. Eur Heart J 20: 641, 1999.
-
34
Banerjee P, Caulfield B, Crowe L, et al: Prolonged electrical muscle stimulation exercise improves strength and aerobic capacity in healthy sedentary adults. J Appl Physiol 99: 2307, 2005.
-
35
Dobsak P, Nováková M, Fiser B, et al: Electrical stimulation of skeletal muscles: an alternative to aerobic exercise training in patients with chronic heart failure? Int Heart J 47: 441, 2006.
-
36
Banerjee P, Caulfield B, Crowe L, et al: Prolonged electrical muscle stimulation exercise improves strength, peak VO2, and exercise capacity in patients with stable chronic heart failure. J Card Fail 15: 319, 2009.
-
37
Vivodtzev I, Debrigaré R, Gagnon P, et al: Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial. Chest 141: 716, 2012.
-
38
Hudlicka O, Brown MD: Adaptation of skeletal muscle microvasculature to increased or decrease blood flow: role of shear stress, nitric oxide and vascular endothelial growth factor. J Vasc Res 46: 504, 2009.
-
39
Medeiros AH, Chalerge ST, De Carvalho CC: Muscle electrostimulation: alternative of adjuvant treatment to patients with peripheral arterial obstructive disease. J Vasc Bras 6: 156, 2007.
-
40
Gregory CM, Bickel CS: Recruitment patterns in human skeletal muscle during electrical stimulation. Phys Ther 85: 358, 2005.
-
41
Kanno S, Oda N, Abe M, et al: Establishment of a simple and practical procedure applicable to therapeutic angiogenesis. Circulation 99: 2682, 1999.
-
42
Milkiewicz M, Hudlicka O, Verhaeg J, et al: Differential expression of Flk-1 and Flt-1 in rat skeletal muscle in response to chronic ischaemia: favourable effect of muscle activation. Clin Sci 105: 473, 2003.
-
43
McDermott MM, Liu K, Ferrucci L, et al: Circulating blood markers and functional impairment in peripheral arterial disease.
Effects of Intermittent Calf Muscle Electrical Stimulation on Walking Capacity in Claudicants Living with Type 2 Diabetes
Background:
First-line therapy for diabetic patients presenting with intermittent claudication includes supervised exercise programs to improve walking distance. However, exercise comes with a variety of barriers and may be contraindicated in certain conditions. The aim of this study was to evaluate whether calf muscle electrostimulation improves claudication distance.
Methods:
A prospective, one-group, pretest-posttest study design was used on 40 participants living with type 2 diabetes mellitus, peripheral artery disease (ankle brachial pressure index, <0.90), and calf muscle claudication. Calf muscle electrostimulation of varying frequencies (1–250 Hz) was prescribed on both limbs for 1-hour daily sessions for 12 consecutive weeks. The absolute claudication distance (ACD) was measured at baseline and after the intervention.
Results:
The recruited cohort (30 men and ten women; mean age, 71 years; mean ankle brachial pressure index, 0.70) registered a mean ± SD baseline ACD of 333.71 ± 208 m. After a mean ± SD of 91.68 ± 6.23 days of electrical stimulation, a significant mean ± SD increase of 137 ± 136 m in the ACD (P = .001, Wilcoxon signed rank test) was registered. Improvement was found to be sex independent, but age was negatively correlated with proportion of improvement (r = –0.361; P = .011, Pearson correlation test).
Conclusions:
Electrical stimulation of varying frequencies on ischemic calf muscles significantly increased the maximal walking capacity in claudicants with type 2 diabetes. This therapeutic approach should be considered in patients with impaired exercise tolerance or as an adjunct treatment modality.
